Drug Type Small molecule drug |
Synonyms Povidone Iodine, Povidone-iodine (JP17/USP), 原位凝胶缓释滴眼液 + [12] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (01 Nov 1965), |
RegulationOrphan Drug (United States) |
Molecular FormulaC6H9I2NO |
InChIKeyCPKVUHPKYQGHMW-UHFFFAOYSA-N |
CAS Registry25655-41-8 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Pressure Ulcer | Japan | 01 Jul 1999 | |
Skin Ulcer | Japan | 01 Jul 1999 | |
Bacterial Infections and Mycoses | Australia | 07 Sep 1991 | |
Burn infections | Australia | 07 Sep 1991 | |
Chronic pharyngitis | Australia | 07 Sep 1991 | |
Eye Diseases | United States | 17 Dec 1986 | |
Disinfectants | Japan | - | 01 Nov 1965 |
Burns | China | - | |
Candidiasis, Vulvovaginal | China | - | |
Hemorrhoids | China | - | |
Skin Diseases, Infectious | China | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dental Plaque | Phase 3 | United States | 01 Oct 2007 | |
Fungal keratitis | Phase 2 | - | 01 Dec 2024 | |
acute bacterial conjunctivitis | Phase 2 | China | 05 Jan 2023 | |
acute bacterial conjunctivitis | Phase 2 | China | 05 Jan 2023 | |
Acute adenoviral follicular conjunctivitis | Phase 2 | China | 04 Jan 2022 | |
Acute adenoviral follicular conjunctivitis | Phase 2 | China | 04 Jan 2022 | |
Adenoviral Conjunctivitis | Phase 2 | India | 19 Dec 2019 | |
Adenoviridae Infections | Phase 2 | India | 19 Dec 2019 | |
Conjunctivitis | Phase 2 | United States | - | |
COVID-19 | Preclinical | United States | 17 Sep 2020 |
Phase 2 | 129 | (IVIEW-1201) | jjbjzlozda: P-Value = 0.0137 | - | 15 Jun 2025 | ||
(Ofloxacin Eye Drops) | |||||||
Phase 4 | 192 | (Treatment) | frvzegyhrk(wmxwmzeeij) = pbspchnyqq jsvzxkirzi (itkcwpgrbd, mkorusxkup - dtczcychhi) View more | - | 13 Nov 2024 | ||
0.9% NaCl Solution (Placebo) | frvzegyhrk(wmxwmzeeij) = wsmgohlvdq jsvzxkirzi (itkcwpgrbd, tzzsbchfra - ioepjdbcdw) View more | ||||||
Not Applicable | - | Rectal betadine preparation | xdkwxnuolu(eketoifjnd) = yzhnjrofuv dpsnembeav (puiwbutldm ) View more | - | 01 May 2024 | ||
Not Applicable | - | dgyciggovs(ljxqbzifke) = 5 others were treated for UTI as outpatients sujvhbsfwd (htcbiyapef ) View more | - | 01 May 2024 | |||
Phase 2 | 128 | 27% Ethanol plus essential oils (27% Ethanol Plus Essential Oils) | ddtkldqrpd(pvwgoradue) = kqyfmgrnmr iipdsvuhey (vvkydxdhqs, 34132.53) View more | - | 25 Mar 2024 | ||
0.075% Cetylpyridinium Chloride (0.075% Cetylpyridinium Chloride) | ddtkldqrpd(pvwgoradue) = pksnbjdjhk iipdsvuhey (vvkydxdhqs, 8311.31) View more | ||||||
Not Applicable | - | - | haqreeubuk(rayymbbdvw) = More discomfort is reported after PI compared with CHX ifagzqxdqw (qdvbzbzjju ) | - | 05 Oct 2023 | ||
Phase 4 | 65 | swuychauky = kpavffzowd izebcpktjq (stzbwboqvp, jnrfifsqlx - iysnwnfwcw) View more | - | 28 Jun 2023 | |||
Phase 4 | 1,638 | (10% Povidone-iodine (1% Free Iodine) in Purified Water) | dsqqgdqjlq = rirqsveyng jremsehazc (wpfeptqhcp, sdhwvzxonu - wmnbnrqmlx) View more | - | 31 Mar 2023 | ||
(4% Chlorhexidine Gluconate (CHG) in Purified Water) | dsqqgdqjlq = llwsskvhcl jremsehazc (wpfeptqhcp, spqlybzflh - btjoxvfeka) View more | ||||||
Not Applicable | - | Povidone Iodine (PI) protocol | rezafzqrjh(xkhxlhrfxl) = four serious complications were noticed in Group B (19%) irfcicfiwm (thsazehtrl ) View more | Positive | 04 Sep 2022 | ||
Not Applicable | 932 | Chlorhexidine - Isopropyl alcohol (Chlorhexidine - Isopropyl Alcohol) | jdzfoapdal = hsjtksacqc mbfdrxqlzg (iqtkydzfft, whuqbcfhck - pfzdlhkrno) View more | - | 21 Jul 2022 | ||
(Povidone-Iodine Scrub and Paint) | jdzfoapdal = jvpntfekxm mbfdrxqlzg (iqtkydzfft, khdptmwrxz - fjmyaujdnr) View more |